Prime Capital Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
14,344
+43
+0.3% +$3.76K 0.01% 463
2026
Q1
$1.22M Buy
14,301
+94
+0.7% +$8.38K 0.01% 464
2025
Q4
$1.12M Sell
14,207
-289
-2% -$22.7K 0.01% 466
2025
Q3
$1.16M Sell
14,496
-1,265
-8% -$108K 0.01% 449
2025
Q2
$1.43M Sell
15,761
-4,405
-22% -$402K 0.02% 395
2025
Q1
$1.89M Buy
20,166
+217
+1% +$19.4K 0.02% 377
2024
Q4
$1.81M Sell
19,949
-4,432
-18% -$423K 0.03% 321
2024
Q3
$2.53M Sell
24,381
-6,620
-21% -$675K 0.04% 279
2024
Q2
$3.01M Sell
31,001
-9,153
-23% -$844K 0.04% 259
2024
Q1
$3.62M Sell
40,154
-29,344
-42% -$2.49M 0.05% 245
2023
Q4
$5.54M Buy
69,498
+48,682
+234% +$3.66M 0.08% 187
2023
Q3
$1.48M Sell
20,816
-1,258
-6% -$94.1K 0.03% 289
2023
Q2
$1.7M Buy
22,074
+7,656
+53% +$593K 0.03% 279
2023
Q1
$1.08M Buy
14,418
+4,765
+49% +$354K 0.04% 237
2022
Q4
$761K Buy
9,653
+5,366
+125% +$402K 0.03% 269
2022
Q3
$301K Buy
+4,287
New +$336K 0.02% 303
2021
Q1
– Sell
-16,462
Closed -$1.41M – 464
2020
Q4
$1.41M Buy
16,462
+1,098
+7% +$90.8K 0.11% 141
2020
Q3
$1.19M Buy
15,364
+13,000
+550% +$991K 0.1% 153
2020
Q2
$173K Buy
2,364
+885
+60% +$62.9K 0.02% 240
2020
Q1
$98K Buy
1,479
+29
+2% +$2.04K 0.01% 237
2019
Q4
$100K Hold
1,450
– – 0.01% 246
2019
Q3
$107K Sell
1,450
-1,400
-49% -$102K 0.02% 242
2019
Q2
$204K Sell
2,850
-1,450
-34% -$103K 0.04% 172
2019
Q1
$295K Buy
+4,300
New +$278K 0.09% 119
2018
Q4
– Sell
-5,200
Closed -$348K – 365
2018
Q3
$348K Buy
5,200
+550
+12% +$36.6K 0.11% 107
2018
Q2
$301K Hold
4,650
– – 0.13% 111
2018
Q1
$333K Hold
4,650
– – 0.24% 79
2017
Q4
$351K Buy
+4,650
New +$340K 0.27% 74

Other funds holding CL

Prime Capital Investment Advisors's CL Position: Q2 2026 in Review

Prime Capital Investment Advisors increased its Colgate-Palmolive (CL) stake by 0.3% in Q2 2026, buying an estimated $3.76K and bringing the position to 14,344 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #463.

Prime Capital Investment Advisors first reported a position in CL in Q4 2017 and has held it in 28 quarters since. The position peaked at $5.54M in Q4 2023. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Prime Capital Investment Advisors held 14,344 shares of Colgate-Palmolive worth $1.32M as of Q2 2026.
  • Prime Capital Investment Advisors bought 43 Colgate-Palmolive shares in Q2 2026, an estimated $3.76K.
  • Colgate-Palmolive made up 0.01% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #463 holding.
  • Prime Capital Investment Advisors first reported a position in Colgate-Palmolive in Q4 2017 and has held it in 28 quarters since.
  • Prime Capital Investment Advisors's Colgate-Palmolive position peaked at $5.54M in Q4 2023.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.